Retatrutide appears to be a new treatment in the fight against obesity. This revolutionary drug, belonging to a dual GLP-1 and GIP receptor agonist, exhibits promising results in research studies. By stimulating these receptors, Retatrutide controls cravings, {promotesenergy expenditure, and ultimately results in significant weight loss. While fur